1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Metastases

Docetaxel for the treatment of hormone-refractory metastatic prostate cancer

Technology appraisal guidance [TA101] Published: 28 June 2006

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Tools and resources

Tools to help you put the guidance into practice.

Implementation support

  • NICEimpact cancer report  
  • Measuring the use of NICE guidance  

Guidance into practice

  • About the Into practice guide  
  • Practical steps to improving the quality of care and services using NICE guidance